Immune Response Under Immunotherapy in Metastatic NSCLC: Sputum, Blood Samples and Microbioata Study

CompletedOBSERVATIONAL
Enrollment

24

Participants

Timeline

Start Date

May 3, 2021

Primary Completion Date

September 26, 2022

Study Completion Date

July 31, 2023

Conditions
Non-squamous Lung CancerMetastatic Lung Cancer
Interventions
OTHER

Blood

Blood samples are taken at each visit to the day hospital for a programmed injection of immunotherapy.

OTHER

sputum

induced by saline aerosol sputum during each visit to the day hospital for a programmed injection of immunotherapy.

OTHER

saliva

spontaneous saliva during each visit to the day hospital for a programmed injection of immunotherapy.

OTHER

stool

Stool analyses will be carried out on a sample taken by the patient at home and brought back at the time of a day hospital.

Trial Locations (2)

37000

University hospital, Tours

90048

Ferreira Marion, Los Angeles

All Listed Sponsors
collaborator

Cedars-Sinai Medical Center

OTHER

lead

University Hospital, Tours

OTHER